Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 4
2020 5
2021 7
2022 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control.
Wajja A, Nassanga B, Natukunda A, Serubanja J, Tumusiime J, Akurut H, Oduru G, Nassuuna J, Kabagenyi J, Morrison H, Scott H, Powell Doherty R, Marshall JL, Cabrera Puig I, Cose S, Kaleebu P, Webb EL, Satti I, McShane H, Elliott AM; TB042 Study Team. Wajja A, et al. Among authors: nassuuna j. Lancet Infect Dis. 2024 Feb;24(2):e78-e79. doi: 10.1016/S1473-3099(23)00758-2. Epub 2024 Jan 3. Lancet Infect Dis. 2024. PMID: 38184003 No abstract available.
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.
Wajja A, Nassanga B, Natukunda A, Serubanja J, Tumusiime J, Akurut H, Oduru G, Nassuuna J, Kabagenyi J, Morrison H, Scott H, Doherty RP, Marshall JL, Puig IC, Cose S, Kaleebu P, Webb EL, Satti I, McShane H, Elliott AM; TB042 Study Team. Wajja A, et al. Among authors: nassuuna j. Lancet Infect Dis. 2024 Mar;24(3):285-296. doi: 10.1016/S1473-3099(23)00501-7. Epub 2023 Nov 25. Lancet Infect Dis. 2024. PMID: 38012890 Free article. Clinical Trial.
Schistosoma mansoni-specific immune responses and allergy in Uganda.
Nkurunungi G, Kabagenyi J, Nampijja M, Sanya RE, Walusimbi B, Nassuuna J, Webb EL, Elliott AM; LaVIISWA study team. Nkurunungi G, et al. Among authors: nassuuna j. Parasite Immunol. 2018 Jan;40(1):e12506. doi: 10.1111/pim.12506. Epub 2017 Dec 15. Parasite Immunol. 2018. PMID: 29171863 Free PMC article.
Cross-reactive carbohydrate determinant-specific IgE obscures true atopy and exhibits ⍺-1,3-fucose epitope-specific inverse associations with asthma.
Nkurunungi G, Mpairwe H, Versteeg SA, van Diepen A, Nassuuna J, Kabagenyi J, Nambuya I, Sanya RE, Nampijja M, Serna S, Reichardt NC, Hokke CH, Webb EL, van Ree R, Yazdanbakhsh M, Elliott AM. Nkurunungi G, et al. Among authors: nassuuna j. Allergy. 2021 Jan;76(1):233-246. doi: 10.1111/all.14469. Epub 2020 Jul 8. Allergy. 2021. PMID: 32568414 Free PMC article.
High prevalence of Schistosoma mansoni infection and stunting among school age children in communities along the Albert-Nile, Northern Uganda: A cross sectional study.
Mulindwa J, Namulondo J, Kitibwa A, Nassuuna J, Nyangiri OA, Kimuda MP, Boobo A, Nerima B, Busingye F, Candia R, Namukuta A, Ssenyonga R, Ukumu N, Ajal P, Adriko M, Noyes H, de Dood CJ, Corstjens PLAM, van Dam GJ, Elliott AM, Matovu E; TrypanoGEN+ Research group. Mulindwa J, et al. Among authors: nassuuna j. PLoS Negl Trop Dis. 2022 Jul 27;16(7):e0010570. doi: 10.1371/journal.pntd.0010570. eCollection 2022 Jul. PLoS Negl Trop Dis. 2022. PMID: 35895705 Free PMC article.
Do helminth infections underpin urban-rural differences in risk factors for allergy-related outcomes?
Nkurunungi G, Lubyayi L, Versteeg SA, Sanya RE, Nassuuna J, Kabagenyi J, Kabuubi PN, Tumusiime J, Zziwa C, Kizindo R, Niwagaba E, Nanyunja C, Nampijja M, Mpairwe H, Yazdanbakhsh M, van Ree R, Webb EL, Elliott AM. Nkurunungi G, et al. Among authors: nassuuna j. Clin Exp Allergy. 2019 May;49(5):663-676. doi: 10.1111/cea.13335. Epub 2019 Jan 25. Clin Exp Allergy. 2019. PMID: 30633850 Free PMC article.
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial.
Abaasa A, Egesa M, Driciru E, Koopman JPR, Kiyemba R, Sanya RE, Nassuuna J, Ssali A, Kimbugwe G, Wajja A, van Dam GJ, Corstjens PLAM, Cose S, Seeley J, Kamuya D, Webb EL, Yazdanbakhsh M, Kaleebu P, Siddiqui AA, Kabatereine N, Tukahebwa E, Roestenberg M, Elliott AM. Abaasa A, et al. Among authors: nassuuna j. Immunother Adv. 2023 Jul 20;3(1):ltad010. doi: 10.1093/immadv/ltad010. eCollection 2023. Immunother Adv. 2023. PMID: 37538934 Free PMC article.
The Effect of Helminth Infections and Their Treatment on Metabolic Outcomes: Results of a Cluster-Randomized Trial.
Sanya RE, Webb EL, Zziwa C, Kizindo R, Sewankambo M, Tumusiime J, Nakazibwe E, Oduru G, Niwagaba E, Nakawungu PK, Kabagenyi J, Nassuuna J, Walusimbi B, Andia-Biraro I, Elliott AM. Sanya RE, et al. Among authors: nassuuna j. Clin Infect Dis. 2020 Jul 27;71(3):601-613. doi: 10.1093/cid/ciz859. Clin Infect Dis. 2020. PMID: 31504336 Free PMC article. Clinical Trial.
Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda.
Koopman JP, Egesa M, Wajja A, Adriko M, Nassuuna J, Nkurunungi G, Driciru E, van Willigen G, Cose S, Yazdanbakhsh M, Kaleebu P, Kabatereine N, Tukahebwa E, Roestenberg M, Elliott AM. Koopman JP, et al. Among authors: nassuuna j. AAS Open Res. 2019 Aug 13;2:17. doi: 10.12688/aasopenres.12972.2. eCollection 2019. AAS Open Res. 2019. PMID: 31819922 Free PMC article.
24 results